The Korean Journal of Cytopathology 15 (1) : 17-27, 2004
|
|
- Stella Arnold
- 5 years ago
- Views:
Transcription
1 5 The Korean Journal of Cytopathology 5 () : 7-7,
2 / 5 / / (human papillomavirus, HPV), 6%, 5% HPV. HPV HPV. HPV HPV,,5 HPV HPV. HPV, 6 HPV. HPV HPV International Agency for Research on Cancer (IARC) HPV DNA ( ) 5. S 6 ( ) ( ).,68, 8 (%), 6 (9.7%), 7 (.5%),,,, (.7%).,68.,6 (6.%).. 99, ml 5 ml. ml -7.. HPV DNA. HPV DNA HPV oligoprobe cocktail GP 5+/6+ primer-mediated PCR-EIA 87 HPV (HPV 6, 8,,, 5, 9, 5, 5, 5, 56, 58, 59, 66, 68) HPV (HPV 6,, 6,,,,,, 5, 5, 55, 57, 6, 7, 7 (CP86), 7, 7, 8 (CP8), 8/IS9, 8 (MM7), 8 (MM8), CP 68 6 HPV DNA Jacobs 7 PCR-EIA. HPV Combita 8 enzyme linked immunoassay HPV 6, 8,,, 58 5 L virus-like particles IgG ( VLPs). 7
3 : HPV Papanicolaou. The Bethesda System, (9.8%), 7 (5.%). (atypical squamous cells of undetermined significance, ASCUS) (atypical glandular cells of undetermined significance, AGUS) (.%), (low-grade squamous intraepithelial lesion, LSIL) 8 (.%), (high-grade squamous intraepithelial lesion, HSIL) (.%), (carcinoma in situ, CIS) (.%), (invasive cervical carcinoma, ICC) (.%) % (/88), 5 5.% (9/7), 5 (Table ). HPV DNA 87 9 (.%), 5, 5 7 (8.6%). 5 HPV DNA %, 6 % (Table ). HPV HPV 9 5 (6%) HPV. HPV 5 HPV, 5 HPV HPV, 5 HPV HPV.5. 5 HPV HPV 6 (Table ). HPV DNA Cytologic diagnosis Age ASCUS (year) Normal LSIL HSIL CIS ICC AGUS < (%) 86 (9.8) (.) 8 (.) (.) (.) (.) 99 () ASCUS; Atypical squamous cells of undetermined significance, AGUS; Atypical glandular cells of undetermined significance, LSIL; Low-grade squamous intraepithelial lesion, HSIL; High-grade squamous intraepithelial lesion, CIS; Carcinoma in situ, ICC; Invasive cervical carcinoma HPV 9 7 (8.9%), HPV,, (Table ). 6 HPV DNA HPV, 57, 6, 7, 7, 7, HPV HPV 7 (5.6%), HPV 6 (.%), HPV (.%) HPV 7, 6, (Table ). HPV DNA 8 7 (8.5%), (7.6%). HPV DNA ASCUS 8 (.%), LSIL 7 9 (5.9%), HSIL 7 (%) HPV DNA (Table ). HPV HPV 7 6 (5.%) ASCUS (5%), LSIL 9 HSIL 7 6 (%) (Table ). HPV 7 HPV 7 (7%), HPV 9 (.9%). 8 (9%) HPV, HPV
4 / 5 / / Age group (year) HPV type <5 (n=7) 5- (n=5) 5- (n=8) 5-5 (n=6) 55 (n=95) (n=87) No. of HPV (+) cases (%) High-risk HPV Low-risk HPV No. of multiple infection type types types types (8.6) (.) (8.9) 6 (.) 7 (8.7) 6 9 (.) Cytologic diagnosis* HPV type Normal (n=8) ASCUS (n=8) LSIL (n=7) HSIL or higher (n=7) (n=86) No. of HPV (+) cases (%) High-risk HPV Others Low-risk HPV 7 8 Others 7 (8.5) (.) 9 (5.9) 9 7 (.) 7 9 (.) * : ASCUS; Atypical squamous cells of undetermined significance, LSIL; Low-grade squamous intraepithelial lesion, HSIL; High-grade squamous intraepithelial lesion : High-risk HPV types other than HPV 6, 8,,, 58, 66 : Low-risk HPV types other than HPV 7, (5%), HPV 58, HPV 66 (Table ). 7 HPV HPV, LSIL HPV. VLPs 86 7 (9.7%), 7 (69%) HPV, 5 (%) 86. VLPs HPV 8 85 (9.7%), HPV 7 (5.9%), HPV 6 55 (9.%), HPV (5%), HPV 58 9 (.%) (Table ). 5, 5 5 % 55 % (Table ).
5 : HPV Age group Type of anti-vpls No. of antibody* No. of antibody (+) cases Age group (year) < Virgins < (9.) 85 (9.7) 6 7 (5.9) 5 (5.) 8 9 (.) ( ) 6 (.7) 9 (.) 9 (.) (.) 86 () 5 /7 ( ) /9 (.8) 57/78 (.5) 5/5 (.) 7/9 (.9) 7/86 (9.7) /7 (.) / ( 6.7) 5/ (.9) * ; The number includes multiple antibody-positive women, ( ) ; percent HPV DNA VLPs. VLPs 5 (.9%), 5 7 (.%) HPV 8,,, 5 (6.7%) HPV 8 (Table ). VLPs 96 VLPs, HPV (7.9%), HPV 65 (7.%), HPV 6 6 (5.%). HPV (9.%), HPV 6 HPV 6 (.8%). 8.% 57.% (Table 5). HPV DNA VLPs 86 HPV HPV DNA 9 9 (.%) 5 HPV, HPV HPV 6, 8,,, 58 (6.7%) HPV Cytologic diagnosis (%) anti-vlps No. HSIL type of cases Normal ASCUS LSIL or higher No. of cases Type of anti-vlps 6 5( 5.7) 6 ( 5.) (.) 5 ( 5.5) ( ) 8 8( 8.9) 7 ( 7.9) (.) (.) (.) 7( 7.8) 65 ( 7.) (.) (.) (.) 9(.) 6 (.) (.) (.) ( ) 58 6(.9) (.5) ( ) (.) (.) 69(9.7) (8.) 6 (7.) 6 (88.9) 5(7.) ASCUS; Atypical squamous cells of undetermined significance, LSIL; Low-grade squamous intraepithelial lesion, HSIL; Highgrade squamous intraepithelial lesion DNA. 5 HPV VLPs 7 5 HPV DNA 7 (8.%) (Table 6). HPV DNA HPV - (HPV type-specific anti-hpv antibody), HPV 6, HPV, HPV 58 7, HPV, HPV 8 HPV 8
6 / 5 / / HPV DNA Any of HPV types * No. of cases Serum anti-vlps Negative (%) Positive (%) Negative (8.) 5 (9.6) Positive 9 7 (78.9) 9 (.) Any of 5 HPV types Negative 8 67 (8.) 56 (8.8) Positive 6 (5.) (6.7) No. of cases (8.) 7 (9.8) * ; high-risk and low-risk HPV types ; High-risk HPV types : HPV 6, 8,,, 58 HPV DNA type Same type anti-vlps Negative Positive HPV 6 Negative 8 7 Positive 7 HPV 8 Negative Positive HPV Negative Positive HPV Negative 87 Positive 7 HPV 58 Negative 8 Positive 5 (Table 7). HPV DNA , %, HPV DNA.%, VLPs 9.8%. HPV.%, 5 (9.%) 9 (.9%), (6%) (.5%) HPV. HPV DNA 5. HPV Stoler 6 HPV DNA %, 9 %,. 5 5, 55 HPV U. HPV. HPV DNA 5 % 9 % HPV. HPV HPV DNA.%, HPV DNA %, ASCUS 5.7%, LSIL 6.%, HSIL 8%. 7 HPV DNA
7 : HPV 8.5%, 7.6% HPV, HSIL %. HPV Castle % ASCUS, 6.% LSIL,.% HSIL, HPV.% ASCUS, Rosendaal 9 HPV CIN III HPV 6. HPV DNA, HPV 6 6 6%, HPV 8 -%, HPV 5-8%, HPV -7%, HPV -5%, HPV 8-95% HPV 6, 8,,, 5 5. HPV 58 HPV 5. HPV HPV HSIL HPV. HPV HPV 6,,,,,, HPV 6,, 5, 5, 7, 7, 7. HPV 6%, LSIL 6 HPV. HPV HPV 6, 7 6, 5. HPV DNA 6 HPV 6 6.6%. HPV DNA 7.5%, %, %,. HPV HPV,,,. HPV DNA 9 HPV 7, 6,, HPV 7 (5.6%). HPV 85 Clifford HPV 7,,.%,.7%,.5%,.%,,. HPV 7.6% (/86), HPV 7 ASCUS, HPV 7 HPV,. 6 HPV 7 HPV, HPV 7 HPV 6,. HPV DNA HPV. HPV HPV.7, 9%. HPV, HPV HPV,, HPV. HPV HPV 8, HPV.8 HPV, HPV 6., Woodman HPV HPV, HPV %, HPV HSIL 6 (-69 ). HPV HSIL 6, HPV HPV DNA 6
8 / 5 / / Schlecht SIL HPV HPV HPV 6.7, HPV 6 8 % SIL. HPV HPV HPV SIL, HPV HPV DNA HPV. Ho HPV 6. HPV HPV 7%, 9%. HPV HSIL HPV., HPV DNA VLPs. VLPs 9.7% HPV DNA.%,.%. HPV Carter %, HPV 6 HPV 6 8. HPV -5% - HPV (type-specific anti-hpv antibody) HPV HPV. HPV HPV. HPV, HPV. 8, HPV. HPV Combita 8 HPV, HPV 8 HPV HPV, HPV 6, HPV 6, 58, HPV 8, 5, 59. HPV HPV -. 5% VLPs, VLPs HPV DNA, 5 HPV DNA HPV. HPV, HPV. 7 HPV 56%, 8%,. 8 Carter HPV 6 HPV 8 HSIL % (/9), HSIL 7% (/7) HPV HSIL. HPV DNA, HPV HPV. HPV DNA HPV HPV. HPV 6 de Gruijl 6 HPV 6 HSIL, HPV 6 HPV 6 HSIL, HPV 6 LSIL
9 : HPV. HSIL HPV 6 HPV 6 8.% HPV 6 69.%, HPV 6. - HPV HPV DNA HPV % (9/9), 5 HPV 6, 8,,, 58 DNA 7% (/). HPV DNA 7 Combita 8 HPV DNA 56% 8%, HPV -. HPV DNA HPV 6,,, HPV - HPV DNA HPV 6 HPV 5 HPV HPV 5 HPV HPV -. HPV -. 8 HPV HPV, HPV HPV DNA - HPV DNA HPV -, HPV -, HPV HPV HPV DNA. HPV DNA 9% HPV DNA 9.6% % 7. VLPs %, % 9.8%. 8 HPV DNA probe, HPV DNA., HPV HPV, AIDS HPV HPV HPV. 5 HPV,,5 HPV. HPV HPV DNA HPV HPV PCR-EIA 6 HPV DNA, ELISA HPV 6, 8,,, 58 5 L virus-like particle IgG ( VLPs), 5.%, ASCUS AGUS.%, LSIL.%, HSIL
10 / 5 / /.%, CIS.%,.%. HPV DNA.%, 5. HPV DNA HPV 7, HPV 6, HPV. HPV 5, HPV DNA HPV 6, 58, 66. HPV 6, 8,,, 58 5 HPV VLPs 9.7%,. VLPs HPV 8,, 6. 5 HPV DNA VLPs (6.7%), HPV DNA -, HPV 6. HPV DNA 8.9%, VLPs %. VLPs.9%. HPV, HPV DNA VLPs HPV.. Ho GYF, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 998;8:-8.. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 977;:-8.. Bosch FX, Lorincz A, Munoz N, Meijier CJLM, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol ;55:-65.. Harro CD, Pang YY, Roden RB, et al. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 6 L virus-like particles vaccine. J Natl Cancer Inst ;9: Evans TG, Bonnez W, Rose RC, et al. Phase I study of a recombinant viruslike particle vaccine against human papillomavirus type in healthy adult volunteers. J Infect Dis ;8: Hwang T. Detection and typing of human papillomavirus DNA by PCR using consensus primers in various cervical lesions of Korean women. J Korean Med Sci 999;: Jacobs MV, Roda Husman AM, van den Brule AJ, Snijders PJ, Meijer CJ, Walboomers JM. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 995;: Combita AL, Bravo MM, Touze A, Orozco O, Coursaget P. Serologic response to human oncogenic papillomavirus types 6, 8,,, 9, 58 and 59 viruslike particles in Colombian women with invasive cervical cancer. Int J Cancer ;97: Sukvirach S, Smith JS, Kesararat W, et al. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. 9th International Papillomavirus Conference ;P-:9.. Pham TH, Nguyen TH, Herrero R, et al. Human papillomavirus infection among women in South and North Vietnam. Br J Cancer ;:-.. Herrero R, Hildesheim A, Bratti C, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst ; 9:6-7.. Lazcano-Ponce E, Herrero R, Mu oz N, et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer ;9:-.. Jacobs MV, Walboomers JM, Snijders PJ, et al. Distribution of 7 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer ;87:-7.. Molano M, Posso H, Weiderpass E, van den Brule AJ, Ronderos M, Franceschi S. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer ;87:-. 5. Shin HR, Lee DH. Cancer incidence in Busan, Korea, Busan: Association of Busan Cancer Registry,. 6. Stoler MH. Advances in cervical screening technology. Mod Pathol ;: Kulasingam SK, Hughes JP, Kiviat NB, et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities. Comparison of sensitivity, specificity, and frequency of referral. JAMA ;88: Castle PE, Wacholder S, Sherman ME, et al. Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women.
11 : HPV Cancer ;95: Rosendaal L, Walboomers JMM, van der Linden JC, et al. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer 996;68: Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cancer worldwide: a meta-analysis. Br J Cancer ;88:6-7.. Schlecht NF, Kulaga S, Robitaille J, et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA ;86:6-.. Woodman CB, Collins S, Winter H, et al. Natural history of cervical papillomavirus infection in young women: a longitudinal cohort study. Lancet ;57:8-6.. Touzè A, de Sanjose S, Coursaget P, et al. Prevalence of anti-human papillomavirus type 6, 8,, and 58 virus-like particles in women in the general population and in prostitutes. J Clin Microbiol ;9:-8.. Carter JJ, Koutsky LA, Hughes JP, et al. Comparison of human papillomavirus types 6, 8, and 6 capsid antibody response following incident infection. J Infect Dis ; 8: Bosch FX, Rohan T, Schneider A, et al. Papillomavirus research update: highlights of the Barcelona HPV international papillomavirus conference. J Clin Pathol ; 5: de Gruijl TD, Bontkes HJ, Walboomers JMM, et al. Immunoglobulin G responses against human papillomavirus type 6 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia. J Natl Cancer Inst 997;89:6-8.
Low grade squamous intra-epithelial lesions and human papillomavirus infection in Colombian women
British Journal of Cancer (2002) 87, 1417 1421 All rights reserved 0007 0920/02 $25.00 www.bjcancer.com Low grade squamous intra-epithelial lesions and human papillomavirus infection in Colombian women
More informationNo HPV High Risk Screening with Genotyping. CPT Code: If Result is NOT DETECTED (x3) If Results is DETECTED (Genotype reported)
CPAL Central Pennsylvania Alliance Laboratory Technical Bulletin No. 117 August 6, 2013 HPV High Risk Screening with Genotyping Contact: Dr. Jeffrey Wisotzkey, 717-851-1422 Director, Molecular Pathology
More informationHuman papillomavirus testing as a cytology gold standard: comparing Surinam with the Netherlands
& 2005 USCAP, Inc All rights reserved 0893-3952/05 $30.00 www.modernpathology.org Human papillomavirus testing as a cytology gold standard: comparing Surinam with the Netherlands Mitchell S Wachtel 1,
More informationFREQUENCY AND RISK FACTORS OF CERVICAL Human papilloma virus INFECTION
Arch. Biol. Sci., Belgrade, 66 (4), 1653-1658, 2014 DOI:10.2298/ABS1404653M FREQUENCY AND RISK FACTORS OF CERVICAL Human papilloma virus INFECTION IN WOMEN IN MONTENEGRO GORDANA MIJOVIĆ 1, TATJANA JOVANOVIĆ
More informationPopulation-Based Human Papillomavirus Prevalence in Lampang and Songkla, Thailand
MAJOR ARTICLE Population-Based Human Papillomavirus Prevalence in Lampang and Songkla, Thailand Sukhon Sukvirach, 1 Jennifer S. Smith, 6 Sirirat Tunsakul, 1 Nubia Muñoz, 6 Vitaya Kesararat, 2 Oranuj Opasatian,
More informationPrevalence and Determinants of High-risk Human Papillomavirus Infection in Women with High Socioeconomic Status in Seoul, Republic of Korea
RESEARCH COMMUNICATION Prevalence and Determinants of High-risk Human Papillomavirus Infection in Women with High Socioeconomic Status in Seoul, Republic of Korea Kidong Kim 1, Jin Ju Kim 2,3, Sun Mie
More informationPopulation-Based Prevalence and Age Distribution of Human Papillomavirus Among Women in Santiago, Chile
Cancer Epidemiology, Biomarkers & Prevention 2271 Short Communication Population-Based Prevalence and Age Distribution of Human Papillomavirus Among Women in Santiago, Chile Catterina Ferreccio, 1 Rodrigo
More informationDevelopment and Duration of Human Papillomavirus Lesions, after Initial Infection
MAJOR ARTICLE Development and Duration of Human Papillomavirus Lesions, after Initial Infection Rachel L. Winer, 1 Nancy B. Kiviat, 2 James P. Hughes, 3 Diane E. Adam, 1 Shu-Kuang Lee, 3 Jane M. Kuypers,
More informationEpidemiologic Profile of Type-Specific Human Papillomavirus Infection and Cervical Neoplasia in Guanacaste, Costa Rica
MAJOR ARTICLE Epidemiologic Profile of Type-Specific Human Papillomavirus Infection and Cervical Neoplasia in Guanacaste, Costa Rica Rolando Herrero, 1,a Philip E. Castle, 2,a Mark Schiffman, 2 M. Concepción
More informationDeterminants of Clearance of Human Papillomavirus Infections in Colombian Women with Normal Cytology: A Population-based, 5-Year Follow-up Study
American Journal of Epidemiology Copyright 2003 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 158, No. 5 Printed in U.S.A. DOI: 10.1093/aje/kwg171 Determinants of Clearance
More informationHuman Papillomavirus Genotypes and the Cumulative 2-Year Risk of Cervical Precancer
MAJOR ARTICLE Human Papillomavirus Genotypes and the Cumulative 2-Year Risk of Cervical Precancer Cosette M. Wheeler, 1,2 William C. Hunt, 1 Mark Schiffman, 3 and Philip E. Castle, 3 for the Atypical Squamous
More informationPhilip E. Castle, Diane Solomon, Mark Schiffman, Cosette M. Wheeler for the ALTS Group
ARTICLEARTICLESHuman Papillomavirus Type 16 Infections and 2-Year Absolute Risk of Cervical Precancer in Women With Equivocal or Mild Cytologic Abnormalities Philip E. Castle, Diane Solomon, Mark Schiffman,
More informationAbnormal Cervicovaginal Cytology With Negative Human Papillomavirus Testing
280 Abnormal Cervicovaginal Cytology With Negative Human Papillomavirus Testing Giovanni Negri, MD Bettina Rigo, BS Fabio Vittadello, ScD Christine Mian, ScD Eduard Egarter-Vigl, MD Department of Pathology,
More informationHuman Papillomavirus Prevalence and Type Distribution Among 968 Women in South Korea
JOURNAL OF CANCER PREVENTION Vol. 21, No. 2, June 2016 http://crossmark.crossref.org/dialog/?doi=10.15430/jcp.2016.21.2.104&domain=pdf&date_stamp=2016-6-30 http://dx.doi.org/10.15430/jcp.2016.21.2.104
More informationPersistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women
British Journal of Cancer (2009) 100, 1184 1190 All rights reserved 0007 0920/09 $32.00 www.bjcancer.com Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort
More informationHuman Papillomaviruses and Cancer: Questions and Answers. Key Points. 1. What are human papillomaviruses, and how are they transmitted?
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Human Papillomaviruses
More informationPromoting Cervical Screening Information for Health Professionals. Cervical Cancer
Promoting Cervical Screening Information for Health Professionals Cervical Cancer PapScreen Victoria Cancer Council Victoria 1 Rathdowne St Carlton VIC 3053 Telephone: (03) 635 5147 Fax: (03) 9635 5360
More informationWoo Dae Kang, Ho Sun Choi, Seok Mo Kim
Is vaccination with quadrivalent HPV vaccine after Loop Electrosurgical Excision Procedure effective in preventing recurrence in patients with High-grade Cervical Intraepithelial Neoplasia (CIN2-3)? Chonnam
More informationPrevalence of Human Papillomavirus Genotypes in Routine Pap Smear of 2,562 Korean Women Determined by PCR-DNA Sequencing
Journal of Bacteriology and Virology 2009. Vol. 39, No. 4 p.337 344 DOI 10.4167/jbv.2009.39.4.337 Original Article Prevalence of Human Papillomavirus Genotypes in Routine Pap Smear of 2,562 Korean Women
More informationA systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions
British Journal of Cancer (2000) 83(5), 561 565 doi: 10.1054/ bjoc.2000.1375, available online at http://www.idealibrary.com on A systematic review of the role of human papilloma virus (HPV) testing within
More informationUnderstanding Your Pap Test Results
Understanding Your Pap Test Results Most laboratories in the United States use a standard set of terms called the Bethesda System to report pap test results. Normal: Pap samples that have no cell abnormalities
More informationHuman papillomavirus infection in Shanxi Province, People s Republic of China: a population-based study
British Journal of Cancer (2006) 95, 96 101 All rights reserved 0007 0920/06 $30.00 www.bjcancer.com Human papillomavirus infection in Shanxi Province, People s Republic of China: a population-based study
More informationHUMAN PAPILLOMAVIRUS INFECTION AND INVASIVE CERVICAL CANCER IN PARAGUAY
Int. J. Cancer: 85, 486 491 (2000) 2000 Wiley-Liss, Inc. Publication of the International Union Against Cancer HUMAN PAPILLOMAVIRUS INFECTION AND INVASIVE CERVICAL CANCER IN PARAGUAY Pedro A. ROLÓN 1,
More informationPrevalence and determinants of HPV infection among Colombian women with normal cytology
British Journal of Cancer (2002) 87, 324 333 ª 2002 Cancer Research UK All rights reserved 0007 0920/02 $25.00 www.bjcancer.com Prevalence and determinants of HPV infection among Colombian women with normal
More informationNatural History of HPV Infections 15/06/2015. Squamous cell carcinoma Adenocarcinoma
14,670 5796 United States/ Canada 17,165 8124 Central America 48,328 21,402 South America 59,929 29,814 Europe 78,896 61,670 Africa 157,759 86,708 Southcentral Asia 61,132 31,314 Eastern Asia 42,538 22,594
More informationISSN X (Print) *Corresponding author Dr. Narotam Sharma
Scholars Journal of Applied Medical Sciences (SJAMS) Sch. J. App. Med. Sci., 2015; 3(8E):3107-3112 Scholars Academic and Scientific Publisher (An International Publisher for Academic and Scientific Resources)
More informationCytomorphologic Features According to HPV DNA Type in Histologically Proven Cases of the Uterine Cervix
The Korean Journal of Pathology 2011; 45: 612-620 http://dx.doi.org/10.4132/koreanjpathol.2011.45.6.612 Cytomorphologic Features According to HPV DNA Type in Histologically Proven Cases of the Uterine
More informationCan HPV-16 Genotyping Provide a Benchmark for Cervical Biopsy Specimen Interpretation?
Anatomic Pathology / Monitoring HPV-16 Fractions in CIN Can HPV-16 Genotyping Provide a Benchmark for Cervical Biopsy Specimen Interpretation? Mary T. Galgano, MD, 1 Philip E. Castle, PhD, MPH, 2 Mark
More informationPersistence of Genital Human Papillomavirus Infection in a Long-Term Follow-Up Study of Female University Students
MAJOR ARTICLE Persistence of Genital Human Papillomavirus Infection in a Long-Term Follow-Up Study of Female University Students Laura K. Sycuro, 1,4 Long Fu Xi, 1 James P. Hughes, 2 Qinghua Feng, 3 Rachel
More informationComparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer
BJOG: an International Journal of Obstetrics and Gynaecology August 2004, Vol. 111, pp. 842 848 DOI: 1 0. 1111/j.1471-0528.2004.00210.x Comparison of HPV test versus conventional and automation-assisted
More informationThe promise of HPV vaccines for Cervical (and other genital cancer) prevention
The promise of HPV vaccines for Cervical (and other genital cancer) prevention CONTROVERSIES IN OBSTETRICS GYNECOLOGY & INFERTILITY Barcelona March 27 F. Xavier Bosch Catalan Institute of Oncology CURRENT
More informationShould Anal Pap Smears Be a Standard of Care in HIV Management?
Should Anal Pap Smears Be a Standard of Care in HIV Management? Gordon Dickinson, M.D., FACP Professor of Medicine and Chief Infectious Diseases, Miller School of Medicine Short Answer: NO But 15-20 HPV
More informationEarly Natural History of Incident, Type-Specific Human Papillomavirus Infections in Newly Sexually Active Young Women
Research Article Cancer Epidemiology, Biomarkers & Prevention Early Natural History of Incident, Type-Specific Human Papillomavirus Infections in Newly Sexually Active Young Women Rachel L. Winer 1, James
More informationAppropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines
Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Tim Kremer, MD Ralph Anderson, MD 1 Objectives Describe the natural history of HPV particularly as it relates
More informationEpidemiology and Natural History of Human Papillomavirus Infections in the Female Genital Tract
Epidemiology and Natural History of Human Papillomavirus Infections in the Female Genital Tract Kevin Ault, Emory University Journal Title: Infectious Diseases in Obstetrics and Gynecology Volume: Volume
More informationDetection and estimation of human papillomavirus viral load in patients with cervical lesions
Bangladesh Med Res Counc Bull 2013; 39: 86-90 Detection and estimation of human papillomavirus viral load in patients with cervical lesions Rahman T 1, Tabassum S 2, Jahan M 2, Nessa A 2, Ashrafunnessa
More informationA Case-Control Study of Risk Factors for Invasive Cervical Cancer among U.S. Women Exposed to Oncogenic Types of Human Papillomavirus
1574 Cancer Epidemiology, Biomarkers & Prevention A Case-Control Study of Risk Factors for Invasive Cervical Cancer among U.S. Women Exposed to Oncogenic Types of Human Papillomavirus Tammy S. Shields,
More informationPapers. Abstract. Introduction. Methods
Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study Susanne
More informationHuman papilloma viruses and cancer in the post-vaccine era
REVIEW 10.1111/j.1469-0691.2009.03032.x Human papilloma viruses and cancer in the post-vaccine era E. Galani and C. Christodoulou Metropolitan Hospital Medical Oncology, Athens, Greece Abstract Human papilloma
More informationPAP smear. (Papanicolaou Test)
PAP smear (Papanicolaou Test) Is a screening test to prevent/ detect cancerous processes in endocervical canal It reduces the mortality caused by cervical cancer up to 80% M. Arbyn; et al. (2010). "European
More informationFor the Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study Group
Effects of Age and Human Papilloma Viral Load on Colposcopy Triage: Data From the Randomized Atypical Squamous Cells of Undetermined Significance/ Low-Grade Squamous Intraepithelial Lesion Triage Study
More informationThe Absolute Risk of Cervical Abnormalities in High-risk Human Papillomavirus Positive, Cytologically Normal Women Over a 10-Year Period
Published Online First on October 23, 2006 as 10.1158/0008-5472.CAN-06-1057 Research Article The Absolute Risk of Cervical Abnormalities in High-risk Human Papillomavirus Positive, Cytologically Normal
More informationOriginal Articles. Do Infection Patterns of Human Papillomavirus Affect the Cytologic Detection of High-Grade Cervical Lesions on Papanicolaou Tests?
Original Articles Do Infection Patterns of Human Papillomavirus Affect the Cytologic Detection of High-Grade Cervical Lesions on Papanicolaou Tests? Siavash Azadmanesh Samimi, MD; Roxanne R. Mody, MD;
More informationOpinion: Cervical cancer a vaccine preventable disease
Opinion: Cervical cancer a vaccine preventable disease Leon Snyman Principal specialist at the Department of Obstetrics and Gynaecology, Gynaecological Oncology unit, University of Pretoria and Kalafong
More informationCan Human Papillomavirus DNA Testing Substitute for Cytology in the Detection of High-Grade Cervical Lesions?
Can Human Papillomavirus DNA Testing Substitute for Cytology in the Detection of High-Grade Cervical Lesions? Kyung-Ju Lee, MD; Jae-Kwan Lee, MD; Ho-Suk Saw, MD, PhD Context. High-risk human papillomaviruses
More informationHPV Genotyping: A New Dimension in Cervical Cancer Screening Tests
HPV Genotyping: A New Dimension in Cervical Cancer Screening Tests Lee P. Shulman MD The Anna Ross Lapham Professor in Obstetrics and Gynecology and Chief, Division of Clinical Genetics Feinberg School
More informationAbstract. Int J Gynecol Cancer 2006, 16,
Int J Gynecol Cancer 2006, 16, 1801 1808 The distribution and differential risks of human papillomavirus genotypes in cervical preinvasive lesions: a Taiwan Cooperative Oncologic Group Study C.-A. CHEN*,
More informationINTRODUCTION HUMAN PAPILLOMAVIRUS
INTRODUCTION HUMAN PAPILLOMAVIRUS Professor Anna-Lise Williamson Institute of Infectious Disease and Molecular Medicine, University of Cape Town National Health Laboratory Service, Groote Schuur Hospital
More informationComparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis
British Journal of Cancer (2003) 89, 101 105 All rights reserved 0007 0920/03 $25.00 www.bjcancer.com Short Communication Comparison of HPV type distribution in high-grade cervical lesions and cervical
More informationThe New England Journal of Medicine
The New England Journal of Medicine Copyright, 1999, by the Massachusetts Medical Society VOLUME 341 N OVEMBER 25, 1999 NUMBER 22 TYPE-SPECIFIC PERSISTENCE OF HUMAN PAPILLOMAVIRUS DNA BEFORE THE DEVELOPMENT
More informationMethods for HPV Detection: Polymerase Chain Reaction Assays
Monsonego J (ed): Emerging Issues on HPV Infections: From Science to Practice. Basel, Karger, 2006, pp 63 72 Methods for HPV Detection: Polymerase Chain Reaction Assays Suzanne M. Garland a,b, Sepehr Tabrizi
More informationAbstract Aim To evaluate the presence of high risk human papillomaviruses (HPV) in cervical smears showing intraepithelial neoplasia
J Clin Pathol 1999;52:17 22 17 Department of Gynaecology, Friedrich Schiller University, Bachstr 18, 07740 Jena, Germany I Nindl B Lotz U Endisch A Schneider Department of Pathology, Friedrich Schiller
More informationOutcome of Atypical Squamous Cells in Cervical Cytology: Follow-up Assessment by Loop Electrical Excision Procedure
The Korean Journal of Pathology 2012; 46: 359-364 ORIGINAL ARTICLE Outcome of Atypical Squamous Cells in Cervical Cytology: Follow-up Assessment by Loop Electrical Excision Procedure Joon Seon Song Ilseon
More informationNew cervical cancer screening strategy: Combined Pap and HPV testing
REVIEW CME CREDIT XIAN WEN JIN, MD, PhD Department of General Internal Medicine, The Cleveland Clinic Foundation KRISTINE ZANOTTI, MD Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation
More informationThe Korean Journal of Cytopathology 13(1): 14-20, 2002
13 1 The Korean Journal of Cytopathology 13(1): 14-20, 2002 : ASCUS 1941 Papanicolaou. The Bethesda System(TBS) 1) 1988, atypical squamous cells of undetermined significance(ascus), low-grade squamous
More informationMaking Sense of Cervical Cancer Screening
Making Sense of Cervical Cancer Screening New Guidelines published November 2012 Tammie Koehler DO, FACOG The incidence of cervical cancer in the US has decreased more than 50% in the past 30 years because
More informationThe carcinogenicity of human papillomavirus types reflects viral evolution
Virology 337 (2005) 76 84 www.elsevier.com/locate/yviro The carcinogenicity of human papillomavirus types reflects viral evolution Mark Schiffman a, *, Rolando Herrero b, Rob DeSalle c, Allan Hildesheim
More informationThe devil is in the details
The cobas KNOW THE RISK For cervical cancer prevention The devil is in the details Leading with the cobas as your primary screening method uncovers disease missed by cytology, and can protect women from
More informationA Prospective Study of High-Grade Cervical Neoplasia Risk Among Human Papillomavirus-Infected Women
A Prospective Study of High-Grade Cervical Neoplasia Risk Among Human Papillomavirus-Infected Women Philip E. Castle, Sholom Wacholder, Attila T. Lorincz, David R. Scott, Mark E. Sherman, Andrew G. Glass,
More information(Pap) results, ie, abnormal squamous cells of undetermined significance (ASCUS). According to
The Role of Human Papillomavirus Type 16/18 Genotyping in Predicting High-Grade Cervical/Vaginal Intraepithelial Neoplasm in Women With Mildly Abnormal Papanicolaou Results Ming Guo, MD 1 ; Yun Gong, MD
More informationHPV type concordance in sexual couples determines the effect of condoms on regression of flat penile lesions
British Journal of Cancer (2005) 92, 1388 1392 All rights reserved 0007 0920/05 $30.00 www.bjcancer.com HPV type concordance in sexual couples determines the effect of condoms on regression of flat penile
More informationEpidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
The new england journal of medicine original article Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer Nubia Muñoz, M.D., F. Xavier Bosch, M.D., Silvia de Sanjosé,
More informationCan human papillomavirus (HPV) genotyping classify non-16/18 high-risk HPV infection by risk stratification?
J Gynecol Oncol. 2016 Nov;27(6):e56 pissn 2005-0380 eissn 2005-0399 Original Article Can human papillomavirus (HPV) genotyping classify non-16/18 high-risk HPV infection by risk stratification? Yeoun Eun
More informationAbstract. Human papillomavirus (HPV) DNA testing is cost-effective 1-3 (S. Kulasingam, PhD, et al, unpublished Atypical
Anatomic Pathology / HPV DNA DETECTION IN ALTS A Comparison of a Prototype PCR Assay and Hybrid Capture 2 for Detection of Carcinogenic Human Papillomavirus DNA in Women With Equivocal or Mildly Abnormal
More informationHPV AND CERVICAL CANCER
HPV AND CERVICAL CANCER DR SANDJONG TIECHOU ISAAC DELON Postgraduate Training in Reproductive Health Research Faculty of Medicine, University of Yaoundé 2007 INTRODUCTION CERVICAL CANCER IS THE SECOND
More informationVasile Goldiş Western University of Arad, Faculty of Medicine, Obstetrics- Gynecology Department, Romania b
Mædica - a Journal of Clinical Medicine ORIGINAL PAPERS Cervical Intraepithelial Neoplasia in the Dr. Salvator Vuia Clinical Obstetrics and Gynecology Hospital - Arad During the 2000-2009 Period Voicu
More informationEradicating Mortality from Cervical Cancer
Eradicating Mortality from Cervical Cancer Michelle Berlin, MD, MPH Vice Chair, Obstetrics & Gynecology Associate Director, Center for Women s Health June 2, 2009 Overview Prevention Human Papilloma Virus
More informationDetection of Human Papillomavirus DNA in Cytologically Normal Women and Subsequent Cervical Squamous Intraepithelial Lesions
Detection of Human Papillomavirus DNA in Cytologically Normal Women and Subsequent Cervical Squamous Intraepithelial Lesions Kai-Li Liaw, Andrew G. Glass, M. Michele Manos, Catherine E. Greer, David R.
More information2 HPV E1,E2,E4,E5,E6,E7 L1,L2 E6,E7 HPV HPV. Ciuffo Shope Jablonska HPV Zur Hausen HPV HPV16. HPV-genome.
58 2 pp.155-164 2008 2. HPV 20 HPV HPV HPV HPV HPV L1 HPV-DNA 16/18 2 HPV16 /18 6/11 4 2 100 1 Ciuffo 1907 20 Shope 1933 Raus 1934 20 70 Jablonska HPV Orth HPV5 8 1983 zur Hausen HPV16 1 HPV-genome 920-8641
More informationA Population-Based Study of Vaginal Human Papillomavirus Infection in Hysterectomized Women
MAJOR ARTICLE A Population-Based Study of Vaginal Human Papillomavirus Infection in Hysterectomized Women Philip E. Castle, 1 Mark Schiffman, 1 M. Concepcion Bratti, 6 Allan Hildesheim, 1 Rolando Herrero,
More informationModeling the Time Dependence of the Association between Human Papillomavirus Infection and Cervical Cancer Precursor Lesions
American Journal of Epidemiology Copyright 2003 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 158, No. 9 Printed in U.S.A. DOI: 10.1093/aje/kwg235 Modeling the Time Dependence
More informationSingle and multiple human papillomavirus infections in cervical abnormalities in Portuguese women
ORIGINAL ARTICLE VIROLOGY Single and multiple human papillomavirus infections in cervical abnormalities in Portuguese women A. Pista*, A. Oliveira*, N. Verdasca and F. Ribeiro National Laboratory of STI
More informationAbsolute Risk of a Subsequent Abnormal Pap among Oncogenic Human Papillomavirus DNA-Positive, Cytologically Negative Women
Absolute Risk of a Subsequent Abnormal Pap among Oncogenic Human Papillomavirus DNA-Positive, Cytologically Negative Women 2145 Philip E. Castle, Ph.D., M.P.H. 1 Sholom Wacholder, Ph.D. 1 Mark E. Sherman,
More informationPrevalence of cervical infection with HPV type 16 and 18 in Vietnam: implications for vaccine campaign
Vu et al. BMC Cancer 2013, 13:53 RESEARCH ARTICLE Open Access Prevalence of cervical infection with HPV type 16 and 18 in Vietnam: implications for vaccine campaign Lan TH Vu 1*, Dieu Bui 2 and Ha TT Le
More informationHuman papillomavirus infections among Japanese
Human papillomavirus infections among Japanese Blackwell Publishing Asia women: age-related prevalence and type-specific risk for cervical cancer Mamiko Onuki, 1 Koji Matsumoto, 1,4 Toyomi Satoh, 1 Akinori
More informationIJC International Journal of Cancer
IJC International Journal of Cancer The risk of cervical cancer associated with specific types of human papillomavirus: a case control study in a UK population Ned G. Powell 1, Sam J. Hibbitts 1, Adam
More informationThe epidemiology of human papillomavirus infection and cervical cancer
Disease Markers 23 (2007) 213 227 213 IOS Press The epidemiology of human papillomavirus infection and cervical cancer F. Xavier Bosch and Silvia de Sanjosé Institut Català d Oncologia, Epidemiology and
More informationVariations in the age-specific curves of human papillomavirus prevalence in women worldwide
Int. J. Cancer: 119, 2677 2684 (2006) ' 2006 Wiley-Liss, Inc. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide Silvia Franceschi 1 *, Rolando Herrero 2, Gary
More informationGynecologic Oncology
Gynecologic Oncology 115 (2009) 257 261 Contents lists available at ScienceDirect Gynecologic Oncology journal homepage: www.elsevier.com/locate/ygyno High-risk HPV DNA detected in less than 2% of over
More informationGSK Medication: Study No.: Title: Rationale: Phase: Study Period Study Design: Centres: Indication: Treatment: Objectives:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationEdinburgh Research Explorer
Edinburgh Research Explorer Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study Citation for published version: Cuschieri, K, Cubie, H,
More informationSIGNIFICANCE OF MOLECULAR DIAGNOSTICS IN HUMAN PAPILLOMA VIRUS (HPV) DETERMINATION
Arch. Biol. Sci., Belgrade, 66 (1), 51-56, 2014 DOI:10.2298/ABS1401051K SIGNIFICANCE OF MOLECULAR DIAGNOSTICS IN HUMAN PAPILLOMA VIRUS (HPV) DETERMINATION G. KOVAČEVIĆ 1, V. MILOŠEVIĆ 1, I. HRNJAKOVIĆ-CVJETKOVIĆ
More informationThe Natural History of Type-specific Human Papillomavirus Infections in Female University Students 1
Vol. 12, 485 490, June 2003 Cancer Epidemiology, Biomarkers & Prevention 485 The Natural History of Type-specific Human Papillomavirus Infections in Female University Students 1 Harriet Richardson, Gail
More informationHuman papiloma virus testing in the cervix of high-risk women: A hospital-based clinicopathological, colposcopic, and cytogenetic study
Research Article Human papiloma virus testing in the cervix of high-risk women: A hospital-based clinicopathological, colposcopic, and cytogenetic study Subhash Bhardwaj 1, Farooq Ahmed Wani 2, Altaf Bandy
More informationPerformance of HPV Testing vs. Cytology for Cervical Cancer Screening in Senegal. Katherine McLean. A thesis submitted in partial fulfillment of the
Performance of HPV Testing vs. Cytology for Cervical Cancer Screening in Senegal Katherine McLean A thesis submitted in partial fulfillment of the requirements for the degree of Master of Public Health
More informationNIH Public Access Author Manuscript J Low Genit Tract Dis. Author manuscript; available in PMC 2010 July 1.
NIH Public Access Author Manuscript Published in final edited form as: J Low Genit Tract Dis. 2009 July ; 13(3): 174 181. doi:10.1097/lgt.0b013e3181909f30. Treatability by Cryotherapy in a Screen-and-Treat
More informationMaterials and Methods
8 A Prospective Study of Human Papillomavirus (HPV) Type 16 DNA Detection by Polymerase Chain Reaction and Its Association with Acquisition and Persistence of Other HPV Types Kai-Li Liaw, 1 Allan Hildesheim,
More informationThe Impact of High-Risk HPV Genotypes Other Than HPV 16/18 on the Natural Course of Abnormal Cervical Cytology: A Korean HPV Cohort Study
pissn 1598-2998, eissn 2005-9256 Cancer Res Treat. 2016;48(4):1313-1320 Original Article http://dx.doi.org/10.4143/crt.2016.013 Open Access The Impact of High-Risk HPV Genotypes Other Than HPV 16/18 on
More informationGUIDELINE FOR SCREENING FOR CERVICAL CANCER: REVISED
GUIDELINE FOR SCREENING FOR CERVICAL CANCER: REVISED This guideline is a revised version of the guideline developed in February 2000, by the Cervical Cancer Screening Working Group. This revised version
More informationType-Specific Incidence and Persistence of HPV Infection among Young Women: A Prospective Study in North India
DOI:http://dx.doi.org/10.7314/APJCP.2012.13.3.1019 Type-Specific Incidence and Persistence of HPV Infection among Young Women in North India RESEARCH COMMUNICATION Type-Specific Incidence and Persistence
More informationClinical Efficacy of Human Papillomavirus DNA Detection in Urine from Patients with Various Cervical Lesions
J Korean Med Sci 2007; 22: 99-104 ISSN 1011-8934 Copyright The Korean Academy of Medical Sciences Clinical Efficacy of Human Papillomavirus DNA Detection in Urine from Patients with Various Cervical Lesions
More informationStudy Number: Title: Rationale: Phase: Study Period Study Design: Centres: Indication Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationSCCPS Scientific Committee Position Paper on HPV Vaccination
SCCPS Scientific Committee Position Paper on HPV Vaccination Adapted from Joint Statement (March 2011) of the: Obstetrical & Gynaecological Society of Singapore (OGSS) Society for Colposcopy and Cervical
More informationRESEARCH ARTICLE. Yue-Yun Wang 1, Li Li 2, Sheng Wei 2, Ji Peng 3, Shi-Xin Yuan 1, Jian-Sheng Xie 1, Zhi-Hua Liu 1 * Abstract.
RESEARCH ARTICLE Human Papillomavirus (HPV) Infection in Women Participating in Cervical Cancer Screening from 2006 to 2010 in Shenzhen City, South China Yue-Yun Wang 1, Li Li 2, Sheng Wei 2, Ji Peng 3,
More informationEpidemiologic Study of Colposcopy in Clinical Centers of Kermanshah, Iran, during 2006 to 2011
Epidemiologic Study of Colposcopy in Clinical Centers of Kermanshah, Iran, during 2006 to 2011 Maryam Zangeneh (1) Maryam Hematti (2) Nasrin Jalilian (1) Seyedeh Nakisa Niknejad (3) (1) Department of Obstetrics
More informationHuman Papillomavirus (HPV) in Atypical Squamous Cervical Cytology: the Invader HPV Test as a New Screening Assay
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 2008, p. 869 875 Vol. 46, No. 3 0095-1137/08/$08.00 0 doi:10.1128/jcm.01424-07 Copyright 2008, American Society for Microbiology. All Rights Reserved. Human Papillomavirus
More informationScreening for the Precursors of Cervical Cancer in the Era of HPV Vaccination. Dr Stella Heley Senior Liaison Physician Victorian Cytology Service
Screening for the Precursors of Cervical Cancer in the Era of HPV Vaccination Dr Stella Heley Senior Liaison Physician Victorian Cytology Service Victorian Cytology Service Dr Stella Heley Dr Siobhan Bourke
More informationClinical Relevance of HPV Genotyping. A New Dimension In Human Papillomavirus Testing. w w w. a u t o g e n o m i c s. c o m
Clinical Relevance of HPV Genotyping A New Dimension In Human Papillomavirus Testing Human Papillomavirus: Incidence HPV prevalence was 26.8% for women in US aged 14 59 yrs 1 20 million Americans are currently
More information